NCT04808843View on ClinicalTrials.gov

A Study to Learn More About How Safe Dienogest is and How Well it Works Under Real World Conditions in Indian Women With Endometriosis

CompletedOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

May 13, 2022

Primary Completion Date

February 5, 2024

Study Completion Date

September 23, 2024

Conditions
Endometriosis Associated Pelvic Pain
Interventions
DRUG

Dienogest (BAY86-5258, Visanne)

Following the physicians' decision.

Trial Locations (1)

Unknown

Many Locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY